Exam 2 - Pharmacology for Anemia Flashcards
vitamins and minerals
- iron (ferrous sulfate)
- vitamin B12
- folic acid
erythropoiesis stimulating agents
- epoetin alfa
drugs for treatment of iron deficiency anemia
- ferrous sulfate (oral)
- ferrous gluconate (oral)
- iron dextran (parenteral)
indications for iron deficiency drugs
- treat and prevent iron deficiency anemia
- treat blood loss
interactions of iron deficiency drugs
- decrease absorption with antacids
- increased absorption with vitamin C
side effects of iron deficiency drugs
- GI upset
- metallic taste
- staining of teeth
- fatal iron toxicity (overdose in children causing liver failure)
- leading cause of poisoning death in children
what is given to treat iron toxicity
- deferoxamine/desferal
- chelating agent
oral administration of iron
- ferrous sulfate and ferrous gluconate
- best absorbed on an empty stomach
- do not crush or chew
- do not give with antacids or calcium supplements (decreased absorption)
- taking with food will decrease gastric irritation
- give with a straw and diluted in OJ to increase absorption
- monitor for teeth staining
parenteral iron administration
- iron dextran
- give test dose
- black box warning: have epi available for possible allergic reaction
- use 1.5 inch needle with z track method to prevent skin staining
treatment of B12 deficiency
- injections of B12 (cyanocobalamin)
- diet: meat, fish, milk, dairy, eggs
treatment of folate deficiency
- multivitamin supplements
- diet: green leafy vegetables, legumes, organ meats
indications for B12 replacement
- low B12 levels
- pernicious anemia
- bariatric surgery patients
- surges where part or all of the stomach has been removed
injectable B12 replacement
- cyanocobalamin
- IM weekly until levels are normal, then monthly
- more rapid improvement
- indicated for patients with severe deficiency or neurological
- well tolerated
indications for folic acid supplements
- folic acid deficiency anemia
- pregnant women to prevent neural tube defects
MOA: erythropoietin stimulating agents
- stimulates erythropoiesis
- increases hemoglobin and reticulocyte counts
when is erythropoietin stimulating agents indicated
- when hemoglobin is less than 10g/dL unless on dialysis
monitoring for patients on erythropoietin stimulating agents
- blood tests weekly to monitor hemoglobin with goal of less than 11 g/dL to decrease risk for clotting
- evaluate iron status before and during treatment, usually will need iron supplementation
side effects of erythropoietin stimulating agents
- hypertension
- serious CV events (increased hematocrit = increased risk)
- progression of certain cancers
- infection site problems
- bone pain
- headache
nursing implications for erythropoietin stimulating agents
- do not give if it has been shaken or frozen
- protect from light
- do not dilute or mix with other drugs
- black box warning
when is erythropoietin stimulating agents contraindicated
- in patients with uncontrolled hypertension